ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr.

In a report released yesterday, Etzer Darout from BMO Capital reiterated a Buy rating on Acrivon Therapeutics, Inc. (ACRV – Research ...

Analysts are optimistic, shown by an upward trend in estimates, reflecting a growing confidence in ICON’s performance trajectory. ICON PLC’s stock recently closed at $212.18, with Stock Target Advisor ...

Ocular Therapeutix (OCUL – Research Report), the Healthcare sector company ... primarily highlighting the progress and potential of Ocular Therapeutix’s clinical trials. The company’s pivotal SOL-1 ...

at 08:10 ICON plc to Present at the Jefferies London Healthcare Conference ICON plc, a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, ...

At this year’s Fall convocation ceremonies on Nov. 20 and 21, the university will honour the achievements of artist, poet and ...

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

"The entertainment value will be epic," the billionaire said.

Researchers found that children whose mothers took extra vitamin D supplements during pregnancy had stronger bones at the age ...

Translational science can help find applications for research discoveries across a wide range of medical issues.

The funding will make the hospital's new MRI truly state-of-the-art by adding new imaging methods, allowing users to see more ...

This report offers a comprehensive analysis of the global cervical cancer research... Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today ...